cT Blank vs. cTx: Navigating a Common AJCC Staging Challenge

Few staging questions generate more discussion among Oncology Data Specialists (ODS-Cs) than when to assign cT Blank versus cTx during clinical staging.

The distinction may seem subtle, but it has important implications for staging accuracy, data quality, and cancer registry reporting. While AJCC guidelines provide definitions for each category, applying those definitions to real-world cases can be challenging, particularly when documentation is incomplete.

Understanding when to use a blank clinical T category and when a cTx designation is appropriate can help registrars code more consistently and avoid unnecessary use of the “X” category.

When Is cTx Assigned?

According to the AJCC Staging Manual, Tx is assigned when there is no information available about the primary tumor or when the primary tumor cannot be assessed.

AJCC also emphasizes that the “X” designation should be used sparingly and only when the criteria are clearly met. In many cases, assigning a Tx or Nx category can prevent stage grouping, making it especially important to verify that the tumor truly cannot be assessed before selecting an X category.

When Should the Clinical T Category Be Left Blank?

If the criteria for cTx are not met, the clinical T category may need to remain blank.

A cT Blank designation typically reflects a lack of sufficient information rather than evidence that the tumor cannot be assessed. In these situations, the registrar may not have access to the documentation needed to determine whether the clinical T category was evaluated or assigned appropriately.

Common scenarios include:

  • No clinical workup was completed before treatment
  • The cancer was discovered incidentally during surgery
  • Documentation is insufficient to determine whether clinical staging criteria were evaluated
  • Required physician assessment information is unavailable

The key difference is that a blank category reflects missing or incomplete information, while cTx indicates documented evidence that the tumor cannot be assessed.

Case Example: Prostate Cancer

Scenario

A prostate biopsy is positive for adenocarcinoma with:

  • Gleason Score 3+4=7
  • Grade Group 2
  • Elevated PSA

The physician documents the patient as cT1c, but the record does not indicate whether a digital rectal exam (DRE) was performed.

Question

Should this case be coded as cT Blank or cTx?

Answer

Code cT Blank.

Although the managing physician documented a cT1c stage, there is no documentation confirming whether a DRE was performed. Because the information needed to validate the clinical T category is incomplete, the criteria for assigning cTx have not been met.

What Changes if the Physician Documents That No DRE Was Performed?

In that situation, cTx would be appropriate.

Documentation confirming that a DRE was not performed provides evidence that the tumor cannot be clinically assessed according to the requirements for assigning a clinical T category. The inability to assess the tumor is known and documented, which supports the use of the X designation.

A Simple Question to Guide Your Decision

When deciding between cT Blank and cTx, ask:

Do I know that the primary tumor cannot be assessed, or do I simply lack enough information to determine whether it was assessed?

If the tumor cannot be assessed, assign cTx.

If documentation is missing, incomplete, or insufficient, assign cT Blank.

This distinction aligns with AJCC guidance and helps support consistent staging practices across cancer registry programs.

Why It Matters

Accurate staging is foundational to cancer registry data quality. Clinical stage information supports treatment planning, outcomes analysis, research initiatives, and public health reporting. Applying cT Blank and cTx correctly helps ensure that staging data accurately reflects the information available in the medical record.

When uncertainty arises, revisit the available documentation and determine whether there is evidence that the tumor could not be assessed or whether the information needed to make that determination is simply unavailable.

Additional Resources

For further guidance on blank versus X staging assignments, consider reviewing:

Mastering the distinction between cT Blank and cTx helps improve staging consistency, strengthens data integrity, and supports more reliable cancer registry reporting.

Supporting Health Information Management Professionals Nationwide

Accurate coding, cancer registry reporting, and data integrity depend on skilled health information professionals. Healthcare organizations across the country continue to face growing demands for experienced talent in oncology data management, coding, CDI, revenue cycle, and health information services.

RCM partners with healthcare organizations to provide qualified HIM professionals who help support compliance, data quality, and operational performance. We also work with experienced HIM professionals seeking new opportunities to advance their careers across a variety of healthcare settings.

Looking for Your Next HIM Opportunity?

Explore current opportunities in health information management, coding, oncology data management, CDI, and related specialties. Visit our jobs portal.

Need HIM Staffing Support?

Whether you’re looking for contract, project-based, or permanent staffing support, our team can help you connect with experienced HIM professionals.  Reach out for staffing support